PL343095A1 - Paroxetine compositions - Google Patents

Paroxetine compositions

Info

Publication number
PL343095A1
PL343095A1 PL99343095A PL34309599A PL343095A1 PL 343095 A1 PL343095 A1 PL 343095A1 PL 99343095 A PL99343095 A PL 99343095A PL 34309599 A PL34309599 A PL 34309599A PL 343095 A1 PL343095 A1 PL 343095A1
Authority
PL
Poland
Prior art keywords
paroxetine compositions
paroxetine
compositions
Prior art date
Application number
PL99343095A
Other languages
English (en)
Inventor
Andrew Simon Craig
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PL343095A1 publication Critical patent/PL343095A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL99343095A 1998-03-24 1999-03-24 Paroxetine compositions PL343095A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Publications (1)

Publication Number Publication Date
PL343095A1 true PL343095A1 (en) 2001-07-30

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99343095A PL343095A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Country Status (20)

Country Link
EP (1) EP1063993A1 (xx)
JP (1) JP2002507569A (xx)
CN (1) CN1125639C (xx)
AP (1) AP2000001914A0 (xx)
AU (1) AU754765B2 (xx)
BG (1) BG104865A (xx)
BR (1) BR9908991A (xx)
CA (1) CA2324612A1 (xx)
EA (1) EA003393B1 (xx)
GB (1) GB9806312D0 (xx)
HU (1) HUP0101326A3 (xx)
ID (1) ID26485A (xx)
IL (1) IL138478A0 (xx)
NO (1) NO313404B1 (xx)
NZ (1) NZ506893A (xx)
PL (1) PL343095A1 (xx)
SK (1) SK14102000A3 (xx)
TR (1) TR200002750T2 (xx)
WO (1) WO1999048499A1 (xx)
ZA (1) ZA200005697B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
MXPA06000111A (es) * 2003-07-02 2006-04-27 Abbott Lab Proceso para preparar formulaciones de farmacos que regulan lipidos.
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
TR200002750T2 (tr) 2000-12-21
IL138478A0 (en) 2001-10-31
ID26485A (id) 2001-01-11
EA003393B1 (ru) 2003-04-24
CA2324612A1 (en) 1999-09-30
EA200000977A1 (ru) 2001-02-26
AU3045199A (en) 1999-10-18
HUP0101326A3 (en) 2002-06-28
BR9908991A (pt) 2000-12-12
WO1999048499A1 (en) 1999-09-30
NO20004740D0 (no) 2000-09-22
AP2000001914A0 (en) 2000-09-30
AU754765B2 (en) 2002-11-21
NO20004740L (no) 2000-10-03
EP1063993A1 (en) 2001-01-03
NO313404B1 (no) 2002-09-30
NZ506893A (en) 2003-06-30
CN1294512A (zh) 2001-05-09
JP2002507569A (ja) 2002-03-12
HUP0101326A2 (hu) 2002-05-29
BG104865A (en) 2001-05-31
SK14102000A3 (sk) 2001-03-12
CN1125639C (zh) 2003-10-29
GB9806312D0 (en) 1998-05-20
ZA200005697B (en) 2001-10-02

Similar Documents

Publication Publication Date Title
AP2000001874A0 (en) Cellecoxib compositions
GB9917982D0 (en) Compositions
GB9811377D0 (en) Compositions
GB9924268D0 (en) Compositions
EP0994183A4 (en) FUNCTIONAL COMPOSITIONS
GB9828861D0 (en) Compositions
IL139733A0 (en) Novel compositions
GB9904049D0 (en) Rapidly-soluble compositions
IL138478A0 (en) Paroxetine compositions
GB2339693B (en) Anti-mollusc compositions
GB9905325D0 (en) Compositions
GB0016470D0 (en) Compositions
GB9812818D0 (en) Dentfrice compositions
GB9905746D0 (en) Compositions
GB9827291D0 (en) Compositions
GB2336535B (en) Compositions
GB9809347D0 (en) Compositions
GB9816050D0 (en) Compositions
GB9827690D0 (en) Compositions
GB9903924D0 (en) Cosmectic compositions
GB9818278D0 (en) Compositions
AU2003200534A1 (en) Paroxetine compositions
GB9811582D0 (en) Compositions
GB9824922D0 (en) Odour-neutralising compositions
GB9817459D0 (en) Compositions